UBS Group
MEDP icon

UBS Group’s Medpace MEDP Stock Holding History

UBS Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$28K – 9293
2020
Q4 		$28K Hold
200
– – ﹤0.01% 6692
2020
Q3 		$22K Hold
200
– – ﹤0.01% 6239
2020
Q2 		$19K Sell
200
-100
-33% -$8.51K ﹤0.01% 6590
2020
Q1 		$22K Sell
300
-200
-40% -$17.4K ﹤0.01% 6436
2019
Q4 		$42K Buy
+500
New +$38.7K ﹤0.01% 6448

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

UBS Group's MEDP Position: Q1 2026 in Review

UBS Group increased its Medpace (MEDP) stake by 3.5% in Q1 2026, buying an estimated $5.92M and bringing the position to 340,433 shares worth $163M. The position accounts for 0.02% of the portfolio, ranked #719.

UBS Group first reported a position in MEDP in Q3 2016 and has held it in 39 quarters since. The position peaked at $185M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • UBS Group held 340,433 shares of Medpace worth $163M as of Q1 2026.
  • UBS Group bought 11,554 Medpace shares in Q1 2026, an estimated $5.92M.
  • Medpace made up 0.02% of UBS Group's portfolio in Q1 2026, its #719 holding.
  • UBS Group first reported a position in Medpace in Q3 2016 and has held it in 39 quarters since.
  • UBS Group's Medpace position peaked at $185M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.